Winter Storm Update – MSK is fully operational. Read more

More Information: Minus iconIcon indicating subtraction, or that the element can be closed. Plus IconIcon indicating addition, or that the element can be opened. Arrow (down) icon.An arrow icon, usually indicating that the containing element can be opened and closed.


Advances in the Treatment of Melanoma

Medical oncologists Paul Chapman and Jedd Wolchok describe two studies of promising new therapies for advanced melanoma.


Skin Cancer: Latest Developments in Detection, Diagnosis, and Treatment

A study has shown that a new drug for melanoma decreased the risk of death by 63 percent for people with advanced disease. The drug, an oral medical called vemurafenib, works by targeting and silencing a particular gene mutation associated with melanoma. Another study revealed that the FDA-approved ipilimumab (Yervoy™) bolsters the body’s immune system in fighting advanced melanoma. This therapy could extend life when combined with traditional chemotherapy.


Advances in Skin Cancer Treatment

Medical experts from Memorial Sloan Kettering discuss new strategies for preventing, diagnosing, and treating skin cancer.


Researchers Caution Against Combining Two Drugs for Treating Metastatic Melanoma

Researchers have found that combining ipilimumab (YervoyTM) and vemurafenib (Zelboraf®) can cause side effects for patients with metastatic melanoma.